Insulin Diluting Medium for Garzulys (water injection) by Meitheal Pharmaceuticals Inc.: new human prescription drug listing

Insulin Diluting Medium for Garzulys: new human prescription drug listing. Dated 104 days ago, it serves as a historical benchmark. Score 80/100. As of 2026-11-03, from U.S. FDA National Drug Code (NDC) Directory via openFDA.

Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA

Free preview: all 13 published fields of this record are shown below. Locked: 499 related FdaNdcDirectoryPulse records and the 5-column CSV export.

FieldValue
ProductInsulin Diluting Medium for Garzulys
Generic namewater injection
NDC71288-909
LabelerMeitheal Pharmaceuticals Inc.
Product typeHUMAN PRESCRIPTION DRUG
Approval pathwayBLA
Application numberBLA761497
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS, SUBCUTANEOUS
Active ingredientsWATER 1 mL/mL
Pharmacologic classInsulin Analog [EPC]
Marketing start2026-07-24
Package configurations1
Peer records CSV (500 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch Insulin Diluting Medium for Garzulys

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock Insulin Diluting Medium for Garzulys + 500 peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL

  • Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
  • Record date: 2026-07-24
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all records free →

Top FdaNdcDirectoryPulse records (HUMAN PRESCRIPTION DRUG first): Norepinephrine Bitartrate by Northstar Rx LLC · Magnesium Sulfate (Magnesium Sulfate Heptahydrate) by SQUARE · Isosorbide Mononitrate by AiPing Pharmaceutical, Inc. · Isosorbide Mononitrate by AiPing Pharmaceutical, Inc. · Isosorbide Mononitrate by AiPing Pharmaceutical, Inc. · Browse all by state and category →

LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Tue, 03 Nov 2026 18:09:00 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: Insulin Diluting Medium for Garzulys and 1,241 HUMAN PRESCRIPTION DRUG peers

  • HUMAN PRESCRIPTION DRUG FdaNdcDirectoryPulse records like this one: 1,241
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every HUMAN PRESCRIPTION DRUG peer: $248,200 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more FdaNdcDirectoryPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

80 / 100 Launch Signal Score

  • Prescription or biologic product.
  • Brand or biologic launch.
  • Injectable: hospital and 503B relevance.
  • Class: Insulin Analog [EPC].

What is the FdaNdcDirectoryPulse record for Insulin Diluting Medium for Garzulys?

Insulin Diluting Medium for Garzulys by Meitheal Pharmaceuticals Inc.: new human prescription drug listing (BLA) starting 2026-07-24.

How does Insulin Diluting Medium for Garzulys compare to other FdaNdcDirectoryPulse records?

It is 104 days old; check the official source for later updates before acting. Its Launch Signal Score of 80/100 puts it among the stronger signals in this feed.

Insulin Diluting Medium for Garzulys vs. top 3 peers

OrganizationLocationRecord date
Insulin Diluting Medium for GarzulysHUMAN PRESCRIPTION DRUG2026-07-24
ENZEEVUHUMAN PRESCRIPTION DRUG2026-10-26
DaptomycinHUMAN PRESCRIPTION DRUG2026-10-22
TechneLiteHUMAN PRESCRIPTION DRUG2026-10-21

Related records

FdaNdcDirectoryPulse: Prescription (Rx) FdaNdcDirectoryPulse: Biologic (BLA)

How to monitor Insulin Diluting Medium for Garzulys and peer biologic (bla) records

Get new FdaNdcDirectoryPulse records like Insulin Diluting Medium for Garzulys by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new listings in your categories

FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.

Often used together